Differences

This shows you the differences between two versions of the page.

--- laura_desveaux [2022/05/07 20:24]
liam
+++ laura_desveaux [2022/05/07 20:55] (current)
liam [Women in Medicine Summit]
@@ Line 13: / Line 13: @@
 ==== University of Toronto ====
-Desveaux is an Assistant Professor in the [[Institute of Health Policy, Management and Evaluation]] at the [[University of Toronto]].
+Desveaux is an Assistant Professor in the [[Institute of Health Policy, Management and Evaluation]] at the [[University of Toronto]].((University of Toronto. //Laura Desveaux.// Institute of Health Policy, Management and Evaluation. Retrieved May 7, 2022, from https://archive.ph/DhdwZ))
 ==== Ontario COVID-19 Science Advisory Table ====
@@ Line 21: / Line 21: @@
 ==== Trillium Health Partners ====
-Desveaux is the Scientific Lead & Learning Health System Program Lead at [[Trillium Health Partners]].((//Laura Desveaux, PhD.// LinkedIn. Retrieved May 7, 2022, from https://www.linkedin.com/in/lauradesveaux/))
+Desveaux is the Scientific Lead & Learning Health System Program Lead at [[Trillium Health Partners]].((//Laura Desveaux, PhD.// LinkedIn. Retrieved May 7, 2022, from https://www.linkedin.com/in/lauradesveaux/)) She is also the Executive Director of [[Women Who Lead]].
+==== E2I Consulting ====
+Desveaux is a principal of [[E2I Consulting]] alongside [[Noah Ivers]].((//Experienced, Evidence-Based Consulting.// E2I Consulting. Retrieved May 7, 2022, from https://archive.ph/FNKqm))
+==== Women in Medicine Summit ====
+Desveaux is associated with the [[Women in Medicine Summit]].((//Laura Desveaux.// Women in Medicine. Retrieved May 7, 2022, from https://archive.ph/HG3HV)) Sponsors for the summit have included [[3M]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:Celgene]], [[pharmaceutical_companies:Genentech]], [[medical_technology_companies:Labcorp]], [[pharmaceutical_companies:Merck]], [[Morgan Stanley]], [[medical_technology_companies:Natera]], [[pharmaceutical_companies:Pfizer]], [[Seattle Genetics]], [[medical_technology_companies:Tempus]], [[US Army Health Care Recruiting]], [[US National Library of Medicine]], [[Vanium Group]], and [[Yale Cancer Center]].((//Sponsors.// Women in Medicine. Retrieved May 7, 2022, from https://www.womeninmedicinesummit.org/sponsors))
+===== Research =====
+Desveaux's research interests include implementation science, [[behaviour change]], program evaluation, and complex interventions.
+==== COVID-19 ====
+In February 2021, Desveaux authored a pre-print paper on [[vaccine hesitancy]] in non-physician health care workers in regards to [[COVID-19 vaccines]].((Desveaux, L., Savage, R. D., Tadrous, M., Kithulegoda, N., Thai, K., Stall, N. M., & Ivers, N. M. (2021). //Beliefs associated with Intentions of Non-Physician Healthcare Workers to Receive the COVID-19 Vaccine in Ontario, Canada.// medRxiv. Preprint. https://doi.org/10.1101/2021.02.19.21251936))